Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Standardized Fecal Microbiota Transplantation for Ulcerative Colitis [Phase 2, Phase 3]
Clinical trial update for standardized fecal microbiota transplantation in ulcerative colitis, currently recruiting in Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy [Phase 3]
Phase 3 trial investigating anti-cytomegalovirus treatment in relapsing ulcerative colitis patients requiring vedolizumab therapy has been t…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients [Phase 2]
Phase 2a study evaluating IcBD-01 enema in active ulcerative colitis is ongoing, status not disclosed.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating fecal microbiota transplantation in combination with dietary fiber for ulcerative colitis; results have been posted…
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice
A real-life practice study evaluating disease control and treatment patterns in moderate to severe inflammatory bowel disease, completed wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA [Phase 4]
Phase 4 trial update characterizing remission status in ulcerative colitis patients treated with 5-ASA.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes
A completed clinical trial evaluating the relationship between vedolizumab therapeutic drug monitoring, inflammation biomarkers, and clinica…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease [Phase 1, Phase 2]
Clinical trial update on fluorescence imaging of adalimumab-680LT in inflammatory bowel disease (Crohn's disease and ulcerative colitis) acr…
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: Phase 2 Dose-finding IMU-838 for Ulcerative Colitis [Phase 2]
Phase 2 dose-finding study of IMU-838 in ulcerative colitis has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Top Down Versus Step up in Pediatric Ulcerative Colitis [Phase 4]
Phase 4 pediatric trial comparing top-down versus step-up strategies in ulcerative colitis patients treated with infliximab is currently rec…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis [Phase 1]
Phase 1 trial evaluating MDGN-002 in adults with Crohn's disease or ulcerative colitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC) [Phase 1]
Phase 1b double-blind, placebo-controlled study of RO7049665 in ulcerative colitis terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis [Phase 3]
A Phase 3 trial comparing Sucrosomial Iron to oral iron sulfate for iron deficiency anemia in patients with ulcerative colitis is underway, …
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 trial evaluating etrasimod in moderately to severely active ulcerative colitis is underway.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis [Phase 3]
Phase 3 trial update on cobitolimod for moderate to severe active left-sided ulcerative colitis; study terminated.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis. [Phase 3]
Phase III multicentre trial of oral mesalazine in patients with mild to moderate ulcerative colitis is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of combining guselkumab with golimumab in moderately to severely active ulcerative…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease [Phase 2]
A Phase 2 study evaluating the testicular safety of filgotinib in adult males with inflammatory bowel disease was terminated; results have b…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis [Phase 4]
A Phase 4 clinical trial update evaluating the efficacy of mesalazine combined with biologics for moderate to severe ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease [Phase 4]
Phase 4 extended access trial of vedolizumab IV in ulcerative colitis and Crohn's disease has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis [Phase 2]
Phase 2 study of LYS006 in mild to moderate ulcerative colitis was terminated; results were posted on 2023-11-09.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC) [Phase 2]
A Phase 2 study evaluating the efficacy and safety of CBP-307 in adults with moderate to severe ulcerative colitis has completed. Results ha…
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) [Phase 2]
Phase 2 clinical trial update for mirikizumab in children and adolescents with ulcerative colitis, completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management [Phase 2]
Phase 2 clinical trial update evaluating tofacitinib for hospitalized acute severe ulcerative colitis management.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN) [Phase 3]
Phase 3 trial comparing oral etrasimod to placebo for moderately to severely active ulcerative colitis in adult Japanese participants has co…